Literature DB >> 3022120

Clearance of thrombin in vivo: significance of alternative pathways.

T H Carlson.   

Abstract

The clearance of thrombin seems to occur at more than one site and by different mechanisms. This contributes to maintaining thrombin at the right concentrations to act optimally on its various substrates, and thus, to produce the proper amount of proteolytic conversions so that coagulation is precisely controlled. The vascular endothelium plays a major role in thrombin regulation and clearance. It contains heparin-like binding sites and thrombomodulin which serve as cofactors for the thrombin-antithrombin III reaction and the activation of protein C, respectively. In addition, thrombomodulin also serves as a receptor for endothelial cell mediated thrombin endocytosis. Thrombin clearance, which occurs following reaction with antithrombin III or thrombomodulin, probably takes place at different stages in hemostasis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022120     DOI: 10.1007/bf00214768

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  58 in total

Review 1.  Protein C activation.

Authors:  C T Esmon; N L Esmon
Journal:  Semin Thromb Hemost       Date:  1984-04       Impact factor: 4.180

2.  Binding of thrombin to cultured human endothelial cells. Nonequilibrium aspects.

Authors:  P Lollar; J C Hoak; W G Owen
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

3.  Comparison of the behaviour in vivo of two molecular forms of antithrombin III.

Authors:  T H Carlson; A C Atencio; T L Simon
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

4.  The interaction of immobilized thrombin with human antithrombin III.

Authors:  E Marciniak; G Gora-Maslak
Journal:  Thromb Haemost       Date:  1984-02-28       Impact factor: 5.249

5.  Inactivation of thrombin by the aortic endothelium.

Authors:  J Swedenborg; M Dryjski; P Olsson
Journal:  Thromb Haemost       Date:  1983-10-31       Impact factor: 5.249

6.  Thrombin activity appearing on the vessel wall after trauma.

Authors:  M Dryjski; P Olsson; J Swedenborg
Journal:  Thromb Haemost       Date:  1985-12-17       Impact factor: 5.249

7.  Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.

Authors:  M Nesheim; M N Blackburn; C M Lawler; K G Mann
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

8.  In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.

Authors:  H E Fuchs; M A Shifman; S V Pizzo
Journal:  Biochim Biophys Acta       Date:  1982-05-27

9.  Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.

Authors:  K A Bauer; T L Goodman; B L Kass; R D Rosenberg
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.

Authors:  J A Marcum; J B McKenney; R D Rosenberg
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more
  2 in total

Review 1.  Revisiting the Pharmacology of Unfractionated Heparin.

Authors:  Abdallah Derbalah; Stephen Duffull; Fiona Newall; Katie Moynihan; Hesham Al-Sallami
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

2.  In vivo-generated thrombin and plasmin do not activate the complement system in baboons.

Authors:  Ravi S Keshari; Robert Silasi; Cristina Lupu; Fletcher B Taylor; Florea Lupu
Journal:  Blood       Date:  2017-10-11       Impact factor: 25.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.